Microsoft shipped 167 security patches in a single month.
That's not a routine update cycle. That's a crisis with a calendar invite.
AI is now finding vulnerabilities faster than companies can fix them — and attackers are using the same tools.
https://t.co/VfqDuKTaoz
AI can now find security vulnerabilities faster than your team can fix them. Microsoft's April Patch Tuesday — 167 patches, active zero-days, a leaked Windows Defender exploit — is the clearest warning yet. Are you patching fast enough?
https://t.co/VfqDuKTaoz
I got tired of alt-tabbing to Excel every time I needed to check a CSV. I wanted to explore the dataset and query using SQL. So I built a fix - read here:
https://t.co/QJy58lRlfQ
#VSCode#DevTools#BuildInPublic#AIdev
Most devs are using AI to write code. Most are doing it wrong.
No guardrails. No review. No structure.
I wrote about what actually works — and why the teams that skipped the process are now paying for it.
https://t.co/nZ6otlMMlx
CSV ClearView is a free VS Code extension with color-coded columns, SQL querying, data profiling, and duplicate detection. No context switching. Just open your CSV and go.
https://t.co/ihO1ni5Vgh
STAY WITH ME.
A few years ago, a patient was referred to me because he was diagnosed with complicated cirrhosis. He had an infection which led to a condition called hepatic encephalopathy (brain failure due to high ammonia levels). The treatment largely involved ammonia reducing therapies. One drug was central to this - Rifaximin - a non-absorbable antibiotic that reduced ammonia in the body. I prescribed him Rifaximin for 6 weeks and advised him follow-up.
He came back to me, not after six weeks, but in 4 weeks, this time, in liver coma (worst stage of brain failure - due to very high ammonia). He spent two days in the ICU and six days in total in the hospital. His hospital bill was close to INR 80,000. He had no insurance and his wife borrowed the money from neighbors and friends to clear hospital dues.
Upon questioning, I found that he was not taking the Rifaximin drug I had prescribed. He was only on the other two drugs (one, a syrup called lactulose for improving ammonia clearance in gut). I was furious, because the patient spent a whole week unecessarily in the ICU and wasted so much money that he never had - just because he was "not compliant" to my orders. I decided it was time for me to school him a bit.
But I was wrong. He was compliant. He had purchased Rifaximin and was on it. For 15 days. Thereafter, he could not afford it. He was an autorickshaw driver who shuttled school children every morning and evening. He could hardly make ends meet. He had two children of his own. The Rifaximin brand I prescribed him was 42 rupees per tablet. He had to consume two a day - which would mean 2520 rupees a month. He just did not have that money - so he skipped it - to not compromise on other important matters - childrens education and food.
He was confused and scared about opting for a cheaper version of Rifaximin because one, he was unsure about the quality of Rifaximin that was not prescribed by me and two, he was "scared" that I would scold him for buying a cheaper Rifaximin and if that got him into trouble.
I was confused and scared about prescribing a cheaper version of Rifaximin because one, I was unsure about the quality of Rifaximin that was not "a good promoted brand" and two, I was "scared" that his family would scold me for prescribing a cheaper Rifaximin and if that got him into trouble.
It is heartbreaking that many doctors still simply don’t trust generic medicines. Too often, they worry that these cheaper options are lower quality or might cause more problems than the big, famous brands. This fear leads them to prescribe expensive drugs instead, and the real tragedy is that it pushes vital healthcare out of reach for the ordinary people who need it most - like my patient.
This narrative, that generic drugs 'are never good' and that only big pharmaceutical marketed drugs are what works has been deeply ingrained into doctors and patients alike - I do not know by whom and since when. Looking back, these strong emotions were based on either opinions, testimonials or second- and third-hand information. Not evidence.
Like I said. Stay with me. This is life changing and will disrupt the drug market in India. Here are the results of The Citizens Generic vs. Brand Drugs Quality Project.
1/11
If you used LinkedIn, make sure you turn off this setting which allows Linkedin to train their AI on your personal information and content. Depending on your app, it'll be under Settings > Data Privacy
That job offer in your inbox might not be real. Even LinkedIn isn’t immune to recruitment scams. Be cautious—the details in this article are eye-opening. https://t.co/ylEMnbrR3y
#CyberSecurity#JobScamAlert#CyberCrime#ScamAwareness
Hackers can steal 2FA codes and private messages from Android phones using a technique called Pixnapping. This works even on the latest Pixel and Samsung flagship phones. Read how this attack takes place: https://t.co/WL3KDyEeA0
#cybersecurity#malware#android
New research reveals Wi-Fi routers can now identify you—even without your phone! Routine Wi-Fi signals are enough to “see” who’s nearby, raising big privacy concerns. Read more about this eye-opening surveillance threat:
https://t.co/k8MOIrFtsg
#Surveillance#Cybersecurity
Major security flaw in India’s Income Tax portal exposed personal and financial details of millions—including Aadhaar numbers and bank data. Fixed now, but for how long was this risk out there?
Read more: https://t.co/7udJRrqYpR
#DataBreach#InfoSec#Privacy#Cybersecurity
Dive into the creation of Claude Code, the revolutionary AI programming tool making waves in the tech industry. Explore its making and how it's reshaping the landscape of AI-powered software development. #TechRevolution#AIFuture https://t.co/LckfU9tlcP
PARENTS: Your children's use of AI for schoolwork might pose a privacy risk.
Kids frequently disclose:
- Personal info
- Family details
- School-related data
- Private thoughts
It's crucial to instill digital security awareness early on!
https://t.co/RbbmQg5Ivs
#DigitalSafety
Samsung has fixed an Android zero-day flaw that was being actively exploited. A similar issue on Apple devices targeted specific individuals as well. #CyberThreats#TechSecurity https://t.co/HPbNtTerVl